Ubs Group Ag Catalent, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Catalent, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,420,230 shares of CTLT stock, worth $83.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,420,230

Previous 1,160,750 22.35%

Holding current value

$83.8 Million

Previous $65.3 Million 31.8%

% of portfolio

0.02%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$56.16 - $60.96 $14.6 Million - $15.8 Million	259,480 Added 22.35%	1,420,230 $86 Million
Q2 2024 Aug 13, 2024	BUY	$53.58 - $57.02 $5.99 Million - $6.38 Million	111,831 Added 10.66%	1,160,750 $65.3 Million
Q1 2024 May 13, 2024	BUY	$42.56 - $59.82 $13.7 Million - $19.3 Million	322,356 Added 44.37%	1,048,919 $59.2 Million
Q4 2023 Feb 09, 2024	BUY	$32.18 - $46.57 $764,339 - $1.11 Million	23,752 Added 3.38%	726,563 $32.6 Million
Q3 2023 Nov 09, 2023	BUY	$44.2 - $50.2 $10.5 Million - $11.9 Million	237,232 Added 50.95%	702,811 $32 Million
Q2 2023 Aug 11, 2023	BUY	$31.86 - $67.26 $12 Million - $25.3 Million	375,823 Added 418.72%	465,579 $20.2 Million
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $2.3 Million - $3.76 Million	50,671 Added 129.64%	89,756 $5.9 Million
Q4 2022 Feb 08, 2023	SELL	$41.39 - $81.0 $2.37 Million - $4.63 Million	-57,207 Reduced 59.41%	39,085 $1.76 Million
Q3 2022 Nov 10, 2022	SELL	$72.36 - $113.1 $734,164 - $1.15 Million	-10,146 Reduced 9.53%	96,292 $6.97 Million
Q2 2022 Aug 10, 2022	SELL	$87.2 - $114.05 $3.01 Million - $3.93 Million	-34,481 Reduced 24.47%	106,438 $11.4 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $6.21 Million - $8.21 Million	-65,924 Reduced 31.87%	140,919 $15.6 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $3.88 Million - $4.52 Million	-32,485 Reduced 13.57%	206,843 $26.5 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $1.13 Million - $1.48 Million	-10,381 Reduced 4.16%	239,328 $31.8 Million
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $779,641 - $898,911	7,770 Added 3.21%	249,709 $27 Million
Q1 2021 May 12, 2021	SELL	$101.51 - $125.27 $2.38 Million - $2.94 Million	-23,481 Reduced 8.85%	241,939 $25.5 Million
Q4 2020 Feb 11, 2021	BUY	$85.88 - $105.36 $5.6 Million - $6.87 Million	65,240 Added 32.59%	265,420 $27.6 Million
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $6.1 Million - $7.76 Million	83,857 Added 72.09%	200,180 $17.1 Million
Q2 2020 Jul 31, 2020	SELL	$48.02 - $79.04 $1.39 Million - $2.29 Million	-28,927 Reduced 19.92%	116,323 $8.53 Million
Q1 2020 May 01, 2020	SELL	$36.95 - $62.95 $904,942 - $1.54 Million	-24,491 Reduced 14.43%	145,250 $7.55 Million
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $5.27 Million - $6.34 Million	112,010 Added 194.02%	169,741 $9.56 Million
Q3 2019 Nov 14, 2019	SELL	$47.45 - $58.05 $1.48 Million - $1.81 Million	-31,106 Reduced 35.01%	57,731 $2.75 Million
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $1.38 Million - $1.9 Million	35,069 Added 65.22%	88,837 $4.82 Million
Q1 2019 May 14, 2019	SELL	$29.84 - $43.92 $50,161 - $73,829	-1,681 Reduced 3.03%	53,768 $2.18 Million
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $113,211 - $175,165	-3,780 Reduced 6.38%	55,449 $1.73 Million
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $3,289 - $3,735	82 Added 0.14%	59,229 $2.7 Million
Q2 2018 Aug 14, 2018	BUY	$38.72 - $42.52 $101,097 - $111,019	2,611 Added 4.62%	59,147 $2.48 Million
Q1 2018 May 15, 2018	SELL	$39.4 - $47.39 $556,091 - $668,862	-14,114 Reduced 19.98%	56,536 $2.32 Million
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $159,366 - $183,953	4,276 Added 6.44%	70,650 $2.9 Million
Q3 2017 Nov 14, 2017	SELL	$33.75 - $41.67 $3.56 Million - $4.4 Million	-105,571 Reduced 61.4%	66,374 $2.65 Million
Q2 2017 Aug 14, 2017	BUY	N/A	105,413 Added 158.44%	171,945 $6.04 Million
Q1 2017 Nov 14, 2017	BUY	N/A	66,532	66,532 $1.88 Million

Others Institutions Holding CTLT

# of Institutions

513

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account